Barry A Springer
Inventor
Stats
- 10 US patents issued
- 15 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 10 US Patents Issued
- 15 US Applications Filed
- 407 Total Citation Count
- Aug 17, 2016 Most Recent Filing
- Dec 23, 1998 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| 3-DIMENSIONAL PHARMACEUTICALS, INC. | 1
1 2 2 | 1998
2000 2001 2004 |
| LIFE TECHNOLOGIES CORPORATION | 4
1 | 1999
2000 |
| JANSSEN PHARMACEUTICA NV | 1
1 2 | 2005
2012 2016 |
| JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. | 1
1 | 2002
2003 |
Inventor Addresses
| Address | Duration |
|---|---|
| Wilmington, DE | May 15, 01 - Nov 21, 06 |
| Wilmington, DE, US | Sep 06, 01 - Nov 14, 17 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| C07D: | HETEROCYCLIC COMPOUNDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 9815790 | 2017 | Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists | 0 |
| 2017/0057,922 | 2017 | CHEMICALLY MODIFIED QUINOLINE AND QUINOLONE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS | 0 |
| 2012/0302,573 | 2012 | METHODS OF INHIBITING PRO MATRIX METALLOPROTEINASE ACTIVATION | 6 |
| 7138374 | 2006 | Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137 | 0 |
| 2006/0110,732 | 2006 | Method for the identification of ligands | 2 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.